Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong · Delayed Price · Currency is HKD 5.29
+0.09 (1.73%)
At close: Dec 12, 2025
HKG:1066 Market Cap
HKG:1066 has a market cap or net worth of 24.03 billion as of December 12, 2025. Its market cap has increased by 16.08% in one year.
Market Cap
24.03B
Enterprise Value
21.24B
Revenue
14.35B
Ranking
n/a
PE Ratio
11.22
Stock Price
5.29
Market Cap Chart
Since February 27, 2004, HKG:1066's market cap has increased from 572.70M to 24.03B, an increase of 4,096.55%. That is a compound annual growth rate of 18.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 24.03B | 14.31% |
| Dec 31, 2024 | 21.02B | -39.55% |
| Dec 29, 2023 | 34.78B | -40.64% |
| Dec 30, 2022 | 58.60B | 33.16% |
| Dec 31, 2021 | 44.00B | -44.46% |
| Dec 31, 2020 | 79.23B | 87.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.82B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 191.29B |
| Innovent Biologics | 146.01B |
| WuXi Biologics | 138.21B |
| Sino Biopharmaceutical | 121.56B |
| Akeso | 114.68B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.28B |